Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly gross margin; no daily interpolation. Q4 FY2025 (2025-12-31): 0.00%.
GROSS MARGIN
N/A
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
N/A
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Jyong Biotech Ltd. Ordinary Shares
Market Cap
$155.86M
Gross Margin
N/A
TTM Avg
0.00%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$156.07M
Gross Margin
49.12%
TTM Avg
60.40%
3Y Avg
67.38%
5Y Avg
70.83%
Market Cap
$158.40M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
16.67%
Market Cap
$152.06M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
1.51%
Market Cap
$151.58M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-29.98%
Market Cap
$161.45M
Gross Margin
63.55%
TTM Avg
56.95%
3Y Avg
54.72%
5Y Avg
65.55%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jyong Biotech Ltd. Ordinary Shares (MENS) | $155.86M | N/A | 0.00% | N/A | N/A |
| Neuronetics, Inc. (STIM)vs › | $156.07M | 49.12% | 60.40% | 67.38% | 70.83% |
| Inogen, Inc. (INGN)vs › | $157.03M | 48.89% | 46.84% | 43.63% | 44.77% |
| Minerva Neurosciences, Inc. (NERV)vs › | $158.40M | 0.00% | 0.00% | 0.00% | 16.67% |
| ALX Oncology Holdings Inc. (ALXO)vs › | $152.06M | 0.00% | 0.00% | 0.00% | 1.51% |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.58M | 0.00% | 0.00% | 0.00% | -29.98% |
| Codexis, Inc. (CDXS)vs › | $150.95M | 83.71% | 79.64% | 78.40% | 78.75% |
| Coherus Oncology, Inc. (CHRS)vs › | $161.45M | 63.55% | 56.95% | 54.72% | 65.55% |
| PepGen Inc. (PEPG)vs › | $161.51M | 0.00% | 0.00% | 0.00% | 0.00% |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $149.18M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
N/A
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
